Wave Life Sciences selected as GSK transitions sIRNA program; $12 million milestone
Wave Life Sciences says it will receive a $12 million milestone payment for candidate selection and is eligible for up to $375 million in milestones per program plus tiered royalties after GSK selects the sIRNA program for further development.
Sept 30 - Wave Life Sciences Ltd said GSK has selected its sIRNA program for transition to GSK for further development. Wave Life Sciences said it will receive a $12 million milestone payment for candidate selection and is eligible for up to $375 million in milestones per program, plus tiered royalties.